Cargando…

B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection

INTRODUCTION: Bepirovirsen (GSK3228836) is an antisense oligonucleotide that induced rapid and prolonged hepatitis B surface antigen (HBsAg) reduction with a favorable safety profile following 4 weeks of treatment in participants with chronic hepatitis B virus (HBV) infection. The objective of the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cremer, Jennifer, Elston, Robert, Campbell, Fiona M., Kendrick, Stuart, Paff, Melanie, Quinn, Geoff, Theodore, Dickens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427703/ https://www.ncbi.nlm.nih.gov/pubmed/37393402 http://dx.doi.org/10.1007/s12325-023-02531-z

Ejemplares similares

Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
por: Yuen, Man-Fung, et al.
Publicado: (2021)

Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses
por: Han, Kelong, et al.
Publicado: (2022)

Comparison of Pharmacokinetics of the GalNAc-Conjugated Antisense Oligonucleotide GSK3389404 in Participants with Chronic Hepatitis B Infection across the Asia-Pacific Region
por: Han, Kelong, et al.
Publicado: (2022)

Localization of unlabeled bepirovirsen antisense oligonucleotide in murine tissues using in situ hybridization and CARS imaging
por: Spencer-Dene, Bradley, et al.
Publicado: (2023)

A Randomized, Double‐Blind, Placebo‐Controlled, First‐Time‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects
por: Han, Kelong, et al.
Publicado: (2019)

Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population
por: Davies, Jane, et al.
Publicado: (2017)

Hepatitis B Virus: Inactive carriers
por: Sharma, Sanjeev Kumar, et al.
Publicado: (2005)

Selective Hepatitis B Virus Vaccination Has Reduced Hepatitis B Virus Transmission in The Netherlands
por: Hahné, Susan, et al.
Publicado: (2013)

Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database Study
por: Gillespie, Iain A., et al.
Publicado: (2022)

Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications
por: Wettengel, Jochen M., et al.
Publicado: (2021)

Genetic variation of hepatitis B surface antigen among acute and chronic hepatitis B virus infections in The Netherlands
por: Cremer, Jeroen, et al.
Publicado: (2018)

Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
por: Jourdain, Gonzague, et al.
Publicado: (2016)

Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016)
por: Lydié, Nathalie, et al.
Publicado: (2018)

Protocol for PPP1R15A-inhibited mouse model establishment with subcutaneous B16F1 tumor and single-cell analysis
por: Wang, Rongjing, et al.
Publicado: (2023)

Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies
por: Gillespie, Iain A., et al.
Publicado: (2023)

Protocol to establish a mouse model for hepatic metastasis of colorectal cancer
por: Zhang, Yajuan, et al.
Publicado: (2023)

Quick and easy purification of murine untouched naive B cells or germinal center B cells by MACS
por: Ramezani-Rad, Parham, et al.
Publicado: (2021)

Promoting HIV, Hepatitis B Virus, and Hepatitis C Virus Screening Among Migrants With a Language Barrier: Protocol for the Development and Evaluation of an Electronic App (Apidé)
por: Thonon, Frédérique, et al.
Publicado: (2021)

Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B
por: Choi, Hannah S.J., et al.
Publicado: (2021)

Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies
por: Gillespie, Iain A., et al.
Publicado: (2023)

LiverClear: A versatile protocol for mouse liver tissue clearing
por: Molina, Laura M., et al.
Publicado: (2022)

Analysis of the interplay between hepatitis B virus-positive hepatocytes and Kupffer cells ex vivo using mice as a model
por: Li, Yumei, et al.
Publicado: (2022)

Hepatitis B in pregnancy
por: Dyson, Jessica Katharine, et al.
Publicado: (2014)

Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial
por: Wu, Qing-Juan, et al.
Publicado: (2020)

Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study
por: Terada-Hirashima, Junko, et al.
Publicado: (2022)

Occult Hepatitis B Virus Infection in Chacma Baboons, South Africa
por: Dickens, Caroline, et al.
Publicado: (2013)

Safety and efficacy of entecavir for the treatment of chronic hepatitis B
por: Osborn, Melissa
Publicado: (2011)

Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
por: Osborn, Melissa K
Publicado: (2009)

Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver
por: Roni, D. Ajith, et al.
Publicado: (2013)

The safety of intracytoplasmic sperm injection in men with hepatitis B
por: Zheng, Zhong, et al.
Publicado: (2016)

XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer
por: Veyssière, Hugo, et al.
Publicado: (2021)

Global, regional, and national prevalence of hepatitis B infection in the general and key populations living with HIV: a systematic review and meta-analysis protocol
por: Leumi, Steve, et al.
Publicado: (2018)

Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials
por: Tran, Tram T., et al.
Publicado: (2015)

Protocol for chronic hepatitis B virus infection mouse model development by patient-derived orthotopic xenografts
por: Nagornykh, Aleksey M., et al.
Publicado: (2022)

LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasis
por: Lacey, Charles, et al.
Publicado: (2022)

B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain
por: Rouers, Angeline, et al.
Publicado: (2023)

Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment
por: Freeland, Catherine, et al.
Publicado: (2021)

Comparison of Immunogenicity and Safety of Diphtheria–Tetanus–Pertussis–Hepatitis B–Haemophilus influenza B (Bio Farma) with Pentabio(®) Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants
por: Fadlyana, Eddy, et al.
Publicado: (2023)

Establishment of an analysis model based on measurement of hepatitis B viral infection serum markers
por: Guang, Yang, et al.
Publicado: (2019)

Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses
por: Otoguro, Teruhime, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g9g6p7ro8qdlbh4s87jd9uqm76